The Amwell Converge™ platform will enable DHA
healthcare teams to deliver connected and seamless in-person,
virtual, and automated care delivery for the Military Health
System
Amwell® (NYSE: AMWL), a leader in hybrid healthcare enablement,
together with Leidos (NYSE: LDOS), a FORTUNE® 500 science and
technology leader, was recently awarded a next-generation contract
to provide a hybrid care technology platform designed to power the
“Digital First” transformation of the Military Health System
(MHS).
Under this task order, the Leidos Partnership for Defense Health
(LPDH) will deliver Amwell Converge™, a comprehensive hybrid care
enablement platform designed to power the full continuum of care
using digital, virtual and automated modalities, and replace the
Military Health System (MHS) Video Connect solution. It will start
at five initial sites followed by a phased enterprise roll-out.
Also included in the contract are a broad spectrum of Amwell
automated care programs that have a proven track record of helping
deliver better health outcomes, including multiple behavioral
health and integrated core telehealth solutions. If all options are
exercised, the task order has a 22-month period of performance with
a total value of up to $180 million to the LPDH.
“Through our world class platform Converge, Amwell is already
enabling hybrid care across the commercial marketplace. With this
agreement, we are pleased to offer our unique capabilities and help
improve access to quality care for the MHS community of users. We
are grateful for their service, and honored to have been chosen to
join Leidos in supporting the Department of Defense as it seeks to
adopt and extend the benefits of hybrid care to the Military Health
System,” said Ido Schoenberg, M.D., chairman and CEO of Amwell.
The DHA’s Digital First initiative brings new capabilities and
enablement to MHS GENESIS, an advanced electronic health record
(EHR) and healthcare system solution that supports military and
Veteran healthcare initiatives. The Converge platform has deep
integration assets and a simple yet powerful user experience that
enables efficient and quality hybrid care delivery. The platform is
already embedded into existing clinical workflows that care teams
rely on, including those within the core EHR that powers MHS
GENESIS. Together, Amwell and LPDH will enable the DHA to leverage
the benefits of hybrid care, improve access to primary and
behavioral health care, and ultimately improve outcomes for the MHS
community.
The DHA supports national security and ensures our nation’s
military teams are ready to deploy. Seeking to leverage innovation
and best practices from the commercial sector, the DHA conducted a
thorough evaluation of the Amwell solution.
“We are delighted that the demonstrated scalability,
flexibility, and comprehensiveness of the Amwell Converge platform,
as evaluated by DHA, uniquely qualifies Amwell to support the DHA’s
Digital First strategies and readiness mission. We are dedicated to
supporting this program with the best that Amwell offers for many
years to come,” said Dr. Schoenberg.
“Digital First addresses DHA’s goal of better outcomes, new
processes, innovation and increased standardization based on
evidence,” said Jason McCarthy, Leidos senior vice president,
Military and Veterans Health Solutions. “As part of our overall MHS
GENESIS effort to enhance patient experience, we, along with
Amwell, are looking forward to providing near real-time,
self-service support and hybrid care options for our customer and
those whom they serve.”
Digital First will support the entire MHS community of users,
which includes 9.6 million active-duty service members, family
members, retirees, and health professionals across the continuum of
care. Through integrated platform solutions, Amwell and Leidos will
help reduce burdens on care teams, improve the mental health and
wellness of beneficiaries, help reduce healthcare costs and
optimize the effective utilization of DHA's clinical resources
across their global enterprise.
About Amwell
Amwell provides a leading hybrid care enablement platform in the
United States and globally, connecting and enabling providers,
insurers, patients, and innovators to deliver greater access to
more affordable, higher quality care. Amwell believes that hybrid
care delivery will transform healthcare. The company offers a
single, comprehensive platform designed to support all digital
health needs from urgent to acute and post-acute care, as well as
chronic care management and healthy living. With nearly two decades
of experience, Amwell powers the hybrid care of more than 55 health
plans, which collectively represent more than 90 million covered
lives, and many of the nation’s largest health systems,
representing over 2,000 hospitals, have access to Amwell solutions.
For more information, please visit
https://business.amwell.com/.
©2023 American Well Corporation. All rights reserved. Amwell®,
SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are
registered trademarks or trademarks of American Well
Corporation.
This press release contains forward-looking statements about us
and our industry that involve substantial risks and uncertainties
and are based on our beliefs and assumptions and on information
currently available to us. All statements other than statements of
historical facts contained in this press release, including
statements regarding our future results of operations, financial
condition, business strategy and plans and objectives of management
for future operations, are forward-looking statements. In some
cases, you can identify forward-looking statements because they
contain words such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “potential,” “predict,”
“project,” “should,” “will,” or “would,” or the negative of these
words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
the forward-looking statements. Forward-looking statements
represent our beliefs and assumptions only as of the date of this
release. These statements, and related risks, uncertainties,
factors and assumptions, include, but are not limited to: weak
growth and increased volatility in the telehealth market; inability
to adapt to rapid technological changes; increased competition from
existing and potential new participants in the healthcare industry;
changes in healthcare laws, regulations or trends and our ability
to operate in the heavily regulated healthcare industry; our
ability to comply with federal and state privacy regulations; the
significant liability that could result from a cybersecurity
breach; and other factors described under ‘Risk Factors’ in our
most recent form 10-K filed with the SEC. These risks are not
exhaustive. Except as required by law, we assume no obligation to
update these forward-looking statements, or to update the reasons
actual results could differ materially from those anticipated in
the forward-looking statements, even if new information becomes
available in the future. Further information on factors that could
cause actual results to differ materially from the results
anticipated by our forward-looking statements is included in the
reports we have filed or will file with the Securities and Exchange
Commission. These filings, when available, are available on the
investor relations section of our website at investors.amwell.com
and on the SEC’s website at www.sec.gov.
Notice of Ownership
All materials contained herein are the property of American Well
Corporation and are copyrighted under United States law and
applicable international copyright laws and treaty provisions. The
materials contained herein are not work product or "work for hire"
on behalf of any third party. The materials contained herein
constitute the confidential information of American Well
Corporation, except for specific data elements provided by third
parties, which are the confidential information of such third
parties. The content contained herein results from the application
of American Well proprietary processes, analytical frameworks,
algorithms, business methods, solution construction aids and
templates, all of which are and remain the property of American
Well Corporation.
Trademark Notice
All of the trademarks, service marks and logos displayed on
these materials (the "Trademark(s)") are registered and
unregistered trademarks of American Well Corporation or third
parties who have licensed their Trademarks to American Well
Corporation. Except as expressly stated in these terms and
conditions, you may not reproduce, display or otherwise use any
Trademark without first obtaining American Well Corporation's
written permission.
©2023 American Well Corporation. All rights reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231019059215/en/
Amwell Media Angela Vogen, Head of External
Communications Press@amwell.com
Amwell Investor Sue Dooley, Head of Investor Relations
susan.dooley@amwell.com
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024